Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 329

1.

Fluorescein for resection of high-grade gliomas: A safety study control in a single center and review of the literature.

Francaviglia N, Iacopino DG, Costantino G, Villa A, Impallaria P, Meli F, Maugeri R.

Surg Neurol Int. 2017 Jul 11;8:145. doi: 10.4103/sni.sni_89_17. eCollection 2017.

2.

Genetic Factors Affecting Intraoperative 5-aminolevulinic Acid-induced Fluorescence of Diffuse Gliomas.

Saito K, Hirai T, Takeshima H, Kadota Y, Yamashita S, Ivanova A, Yokogami K.

Radiol Oncol. 2017 Apr 12;51(2):142-150. doi: 10.1515/raon-2017-0019. eCollection 2017 Jun.

3.

The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma.

Zeh R, Sheikh S, Xia L, Pierce J, Newton A, Predina J, Cho S, Nasrallah M, Singhal S, Dorsey J, Lee JYK.

PLoS One. 2017 Jul 24;12(7):e0182034. doi: 10.1371/journal.pone.0182034. eCollection 2017.

4.

A Bioengineered Peptide that Localizes to and Illuminates Medulloblastoma: A New Tool with Potential for Fluorescence-Guided Surgical Resection.

Ackerman SE, Wilson CM, Kahn SA, Kintzing JR, Jindal DA, Cheshier SH, Grant GA, Cochran JR.

Cureus. 2014;6(9). pii: e207. doi: 10.7759/cureus.207. Epub 2014 Sep 17.

5.

The Challenges of Management of High-grade Gliomas in Nigeria.

Ndubuisi CA, Mezue WC, Nzegwu M, Okwunodulu O, Ejembi G, Ohaegbulam SC.

J Neurosci Rural Pract. 2017 Jul-Sep;8(3):407-411. doi: 10.4103/jnrp.jnrp_18_17.

6.

Validation and Comparison of the Therapeutic Efficacy of Boron Neutron Capture Therapy Mediated By Boron-Rich Liposomes in Multiple Murine Tumor Models.

Maitz CA, Khan AA, Kueffer PJ, Brockman JD, Dixson J, Jalisatgi SS, Nigg DW, Everett TA, Hawthorne MF.

Transl Oncol. 2017 Aug;10(4):686-692. doi: 10.1016/j.tranon.2017.05.003. Epub 2017 Jul 3.

7.

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.

Roh TH, Park HH, Kang SG, Moon JH, Kim EH, Hong CK, Ahn SS, Choi HJ, Cho J, Kim SH, Lee SK, Kim DS, Kim SH, Suh CO, Lee KS, Chang JH.

Medicine (Baltimore). 2017 Jul;96(27):e7422. doi: 10.1097/MD.0000000000007422.

8.

Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma.

Kessel KA, Hesse J, Straube C, Zimmer C, Schmidt-Graf F, Schlegel J, Meyer B, Combs SE.

PLoS One. 2017 Jul 5;12(7):e0180457. doi: 10.1371/journal.pone.0180457. eCollection 2017.

9.

Review of intraoperative optical coherence tomography: technology and applications [Invited].

Carrasco-Zevallos OM, Viehland C, Keller B, Draelos M, Kuo AN, Toth CA, Izatt JA.

Biomed Opt Express. 2017 Feb 21;8(3):1607-1637. doi: 10.1364/BOE.8.001607. eCollection 2017 Mar 1.

10.

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.

Inogés S, Tejada S, de Cerio AL, Gállego Pérez-Larraya J, Espinós J, Idoate MA, Domínguez PD, de Eulate RG, Aristu J, Bendandi M, Pastor F, Alonso M, Andreu E, Cardoso FP, Valle RD.

J Transl Med. 2017 May 12;15(1):104. doi: 10.1186/s12967-017-1202-z.

11.

Concurrent activation of β2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.

Wnorowski A, Such J, Paul RK, Wersto RP, Indig FE, Jozwiak K, Bernier M, Wainer IW.

Cell Signal. 2017 Aug;36:176-188. doi: 10.1016/j.cellsig.2017.05.006. Epub 2017 May 8.

PMID:
28495590
12.

Semi-automated brain tumor segmentation on multi-parametric MRI using regularized non-negative matrix factorization.

Sauwen N, Acou M, Sima DM, Veraart J, Maes F, Himmelreich U, Achten E, Huffel SV.

BMC Med Imaging. 2017 May 4;17(1):29. doi: 10.1186/s12880-017-0198-4.

13.

Serum endocan levels before and after surgery on low-grade gliomas.

Tanriverdi T, Kemerdere R, Inal BB, Yuksel O, Emre HO, Ahmedov M, Baran O, Ates S.

Surg Neurol Int. 2017 Mar 14;8:32. doi: 10.4103/sni.sni_405_16. eCollection 2017.

14.

Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas.

Yamamoto J, Kakeda S, Yoneda T, Ogura SI, Shimajiri S, Tanaka T, Korogi Y, Nishizawa S.

Oncol Lett. 2017 Mar;13(3):1269-1275. doi: 10.3892/ol.2016.5539. Epub 2016 Dec 27.

15.

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS.

Neuro Oncol. 2017 May 1;19(5):669-677. doi: 10.1093/neuonc/now208.

PMID:
28453749
16.

Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.

Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF.

Neuro Oncol. 2017 May 1;19(5):660-668. doi: 10.1093/neuonc/now239.

PMID:
28453745
17.

Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.

Furuta T, Sabit H, Dong Y, Miyashita K, Kinoshita M, Uchiyama N, Hayashi Y, Hayashi Y, Minamoto T, Nakada M.

Oncotarget. 2017 Apr 4;8(14):22811-22824. doi: 10.18632/oncotarget.15206.

18.

Clinical predictors for survival and treatment outcome of high-grade glioma in Prasat Neurological Institute.

Noiphithak R, Veerasarn K.

Asian J Neurosurg. 2017 Jan-Mar;12(1):28-33. doi: 10.4103/1793-5482.148791.

19.

Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma.

Taylor EN, Ding Y, Zhu S, Cheah E, Alexander P, Lin L, Aninwene GE 2nd, Hoffman MP, Mahajan A, Mohamed ASR, McDannold N, Fuller CD, Chen CC, Gilbert RJ.

Oncotarget. 2017 Jun 27;8(26):41815-41826. doi: 10.18632/oncotarget.16296.

20.

A novel technique of serial biopsy in mouse brain tumour models.

Rogers S, Hii H, Huang J, Ancliffe M, Gottardo NG, Dallas P, Lee S, Endersby R.

PLoS One. 2017 Apr 10;12(4):e0175169. doi: 10.1371/journal.pone.0175169. eCollection 2017.

Supplemental Content

Support Center